Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a/b Non-randomized, Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Sterile BPM31510 (Ubidecarenone, USP) Nanosuspension Injection Administered Intravenously to Patients With Solid Tumors

NCT01957735 is registered in ClinicalTrials.gov with BPGbio as lead sponsor.

NCT NCT01957735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01957735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a/b Non-randomized, Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Sterile BPM31510 (Ubidecarenone, USP) Nanosuspension Injection Administered Intravenously to Patients With Solid Tumors
Lead sponsor
BPGbio
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
February 1, 2017
Enrollment
97 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastatic cancer, solid tumor